The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
This study has been completed.
Sponsor:
Massachusetts General Hospital
Collaborator:
Eli Lilly and Company
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00438971
First received: February 20, 2007
Last updated: July 21, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2009 |
| Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |